Cargando…

Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments

Objectives To describe the potential benefits and harms of zanamivir. Design Systematic review of clinical study reports of randomised placebo controlled trials and regulatory information Data sources Clinical study reports, trial registries, electronic databases, regulatory archives, and correspond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heneghan, Carl J, Onakpoya, Igho, Thompson, Matthew, Spencer, Elizabeth A, Jones, Mark, Jefferson, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981976/ https://www.ncbi.nlm.nih.gov/pubmed/24811412 http://dx.doi.org/10.1136/bmj.g2547

Ejemplares similares

Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments
por: Jefferson, Tom, et al.
Publicado: (2014)

Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
por: Jefferson, Tom, et al.
Publicado: (2014)

Effectiveness, safety and costs of orphan drugs: an evidence-based review
por: Onakpoya, Igho J, et al.
Publicado: (2015)

Transmission of SARS-CoV-2 from pre and asymptomatic infected individuals: a systematic review update
por: Jefferson, Tom, et al.
Publicado: (2022)

A Hierarchical Framework for Assessing Transmission Causality of Respiratory Viruses
por: Jefferson, Tom, et al.
Publicado: (2022)

Risk of bias in industry-funded oseltamivir trials: comparison of core reports versus full clinical study reports
por: Jefferson, Tom, et al.
Publicado: (2014)

SARS-CoV-2 and the role of fomite transmission: a systematic review
por: Onakpoya, Igho J., et al.
Publicado: (2021)

SARS-CoV-2 and the role of orofecal transmission: a systematic review
por: Heneghan, Carl J., et al.
Publicado: (2021)

SARS-CoV-2 and the role of close contact in transmission: a systematic review
por: Onakpoya, Igho J., et al.
Publicado: (2022)

Zanamivir for the prevention of influenza in adults and children age 5 years and older
por: Eiland, Lea S, et al.
Publicado: (2007)

Transmission of SARS-CoV-2 Associated with Cruise Ship Travel: A Systematic Review
por: Rosca, Elena Cecilia, et al.
Publicado: (2022)

Intravenous zanamivir for influenza myocarditis and enteral malabsorption
por: Jahns, Fritz-Patrick, et al.
Publicado: (2018)

Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process
por: Heneghan, Carl J, et al.
Publicado: (2017)

Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) from pre and asymptomatic infected individuals: a systematic review
por: Jefferson, Tom, et al.
Publicado: (2022)

Coinfection with Strongyloides and SARS-CoV-2: A Systematic Review
por: Rosca, Elena C., et al.
Publicado: (2023)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
por: Onakpoya, Igho J., et al.
Publicado: (2016)

Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysis
por: Onakpoya, Igho J, et al.
Publicado: (2015)

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review
por: Onakpoya, Igho J., et al.
Publicado: (2016)

Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
por: Onakpoya, Igho J., et al.
Publicado: (2019)

Protocol for an overview of systematic reviews of interventions to reduce unscheduled hospital admissions among adults
por: Bobrovitz, Niklas, et al.
Publicado: (2015)

Oral hormone pregnancy tests and the risks of congenital malformations: a systematic review and meta-analysis
por: Heneghan, Carl, et al.
Publicado: (2019)

Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials
por: Onakpoya, Igho J, et al.
Publicado: (2019)

Comparison of efficacy and safety of oseltamivir and zanamivir in pandemic influenza treatment
por: Tuna, Nazan, et al.
Publicado: (2012)

Assessing agreement of blood pressure-measuring devices in Tibetan areas of China: a systematic review
por: Mingji, Cuomu, et al.
Publicado: (2016)

Covered stents versus balloon angioplasty for failure of arteriovenous access: a systematic review and meta-analysis
por: Ng, Benjamin, et al.
Publicado: (2021)

Biomarkers for diagnosing serious bacterial infections in older outpatients: a systematic review
por: Gbinigie, Oghenekome A., et al.
Publicado: (2019)

Zanamivir should be inhaled, not nebulised
por: Eagel, Barry A
Publicado: (2010)

Relationship between altitude and the prevalence of hypertension in Tibet: a systematic review
por: Mingji, Cuomu, et al.
Publicado: (2015)

Recommendations of high-quality clinical practice guidelines related to the process of starting dialysis: A systematic review
por: Salas-Gama, Karla, et al.
Publicado: (2022)

Population Pharmacokinetic/Pharmacodynamic Analysis of Intravenous Zanamivir in Healthy Adults and Hospitalized Adult and Pediatric Subjects With Influenza
por: Zuo, Peiying, et al.
Publicado: (2019)

Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: systematic review of systematic reviews
por: Collins, Dylan R J, et al.
Publicado: (2017)

Zanamivir versus trivalent split virus influenza vaccine: a pilot randomized trial
por: Coleman, Brenda L, et al.
Publicado: (2015)

Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs
por: Dholakia, Dhwani, et al.
Publicado: (2016)

The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model
por: Morokutti-Kurz, Martina, et al.
Publicado: (2015)

A Review of Clinical Influenza A and B Infections With Reduced Susceptibility to Both Oseltamivir and Zanamivir
por: Abed, Yacine, et al.
Publicado: (2017)

Zanamivir aqueous solution in severe influenza: A global Compassionate Use Program, 2009–2019
por: Wang‐Jairaj, Jie, et al.
Publicado: (2021)

Withdrawn medicines included in the essential medicines lists of 136 countries
por: Charles, Onella, et al.
Publicado: (2019)

Neuraminidase Inhibitor Zanamivir Ameliorates Collagen-Induced Arthritis
por: Sehnert, Bettina, et al.
Publicado: (2021)

Permeability Enhancers Dramatically Increase Zanamivir Absolute Bioavailability in Rats: Implications for an Orally Bioavailable Influenza Treatment
por: Holmes, Eric H., et al.
Publicado: (2013)

Study of Oseltamivir and Zanamivir Resistance-Related Mutations in Influenza Viruses Isolated from Wild Mallards in Sweden
por: Orozovic, Goran, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tl3a1ikbq0i6rqs4hfal2phtej